Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avid Bioservices Inc CDMO

Healthcare Biotechnology
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing of biologics for the biotechnology and biopharmaceutical industries. It operates in a single segment, which is contract manufacturing and development services... see more

Recent & Breaking News (NDAQ:CDMO)

Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments

GlobeNewswire July 16, 2018

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2018 After Market Close on July 16, 2018

GlobeNewswire July 9, 2018

Avid Bioservices Added to Russell 3000® Index and Russell 2000® Index

GlobeNewswire June 25, 2018

Consolidated Research: 2018 Summary Expectations for Rayonier Advanced Materials, CYS Investments, Avid Bioservices, American Airlines Group, Exelixis, and International Business Machines — Fundamental Analysis, Key Performance Indications

GlobeNewswire June 14, 2018

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

GlobeNewswire June 6, 2018

Avid Bioservices to Participate at BIO International Convention 2018

GlobeNewswire May 29, 2018

Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences

GlobeNewswire May 8, 2018

Avid Bioservices to Participate at INTERPHEX 2018

GlobeNewswire April 9, 2018

Avid Bioservices Receives Six 2018 CMO Leadership Awards

GlobeNewswire March 22, 2018

Avid Bioservices to Participate at Upcoming CDMO Industry Conferences

GlobeNewswire March 13, 2018

Peregrine Pharmaceuticals, Inc. to Host Earnings Call

Accesswire March 12, 2018

Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock

GlobeNewswire March 7, 2018

Avid Bioservices to Present at the 30th Annual ROTH Conference

GlobeNewswire March 6, 2018

Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2018 After Market Close on March 12, 2018

GlobeNewswire March 5, 2018

Avid Bioservices Selected by Acumen Pharmaceuticals to Lead Process Development and Clinical Manufacture of Novel Alzheimer’s Disease Candidate

GlobeNewswire March 1, 2018

Avid Bioservices Announces Resignation of Chief Financial Officer

GlobeNewswire February 26, 2018

Avid Bioservices Selected as Commercial Manufacturer for Critical Enzyme Replacement Therapy by Enzyvant, a Subsidiary of Roivant Sciences

GlobeNewswire February 21, 2018

Avid Bioservices Announces Closing of Public Offering of Common Stock

GlobeNewswire February 20, 2018

Mid-Day Market Update: SolarEdge Technologies Gains Following Q4 Earnings Beat; Avid Bioservices Shares Slide

Benzinga.com  February 15, 2018

Mid-Morning Market Update: Markets Open Higher; Cisco Profit Tops Estimates

Benzinga.com  February 15, 2018